Diabetes, Vol 42, Issue 5 764-772, Copyright © 1993 by American Diabetes Association

ARTICLES

In vivo glucose metabolism in obese and type II diabetic subjects with or without hypertension

E Bonora, RC Bonadonna, S Del Prato, G Gulli, A Solini, M Matsuda and RA DeFronzo
Department of Internal Medicine, University of Texas Health Science Center, San Antonio.

This study examined whether the presence of hypertension, an insulin-resistant condition, exacerbates the defect in insulin action observed in obesity and type II diabetes mellitus. Glucose metabolism in the basal state and in response to insulin was quantitated by using the euglycemic insulin (20 mU.min-1 x m-2) clamp in combination with 3-[3H]glucose infusion and indirect calorimetry in 20 obese nondiabetic subjects (10 hypertensive and 10 normotensive), 26 type II diabetic subjects (13 hypertensive and 13 normotensive), and 11 normal nondiabetic subjects. The two groups of obese subjects and the two groups of diabetic subjects were matched for sex, age, race, body mass index, and fat distribution. Both in the basal state and during insulin infusion, glucose disposal rates (total, oxidative, and nonoxidative) were similar in obese subjects with or without hypertension. Compared with control subjects, both groups of obese subjects were markedly insulin resistant. Similarly, type II diabetic individuals, whether normotensive or hypertensive, were equally insulin resistant. The severity of insulin resistance was nearly identical in obese and diabetic groups. In diabetic subjects, the inhibitory effect of insulin on hepatic glucose output, lipolysis, and lipid oxidation was blunted compared with normal subjects. In obese subjects the ability of insulin to inhibit lipolysis and lipid oxidation was impaired. However, hypertension did not alter the suppressive effects of insulin on hepatic glucose production, plasma free fatty acid levels, or lipid oxidation in either obese or type II diabetic subjects. These results indicate that hypertension does not confer a greater severity of insulin resistance than that already is present in obesity and type II diabetes mellitus.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				the Metascreen Writing Committee The Metabolic Syndrome Is a Risk Indicator of Microvascular and Macrovascular Complications in Diabetes: Results from Metascreen, a multicenter diabetes clinic-based survey Diabetes Care, December 1, 2006; 29(12): 2701 - 2707. [Abstract] [Full Text] [PDF]

				T. Coll, M. Jove, R. Rodriguez-Calvo, E. Eyre, X. Palomer, R. M. Sanchez, M. Merlos, J. C. Laguna, and M. Vazquez-Carrera Palmitate-Mediated Downregulation of Peroxisome Proliferator-Activated Receptor-{gamma} Coactivator 1{alpha} in Skeletal Muscle Cells Involves MEK1/2 and Nuclear Factor-{kappa}B Activation. Diabetes, October 1, 2006; 55(10): 2779 - 2787. [Abstract] [Full Text] [PDF]

				D. K. Richardson, S. Kashyap, M. Bajaj, K. Cusi, S. J. Mandarino, J. Finlayson, R. A. DeFronzo, C. P. Jenkinson, and L. J. Mandarino Lipid Infusion Decreases the Expression of Nuclear Encoded Mitochondrial Genes and Increases the Expression of Extracellular Matrix Genes in Human Skeletal Muscle J. Biol. Chem., March 18, 2005; 280(11): 10290 - 10297. [Abstract] [Full Text] [PDF]

				M. F. Saad, M. Rewers, J. Selby, G. Howard, S. Jinagouda, S. Fahmi, D. Zaccaro, R. N. Bergman, P. J. Savage, and S. M. Haffner Insulin Resistance and Hypertension: The Insulin Resistance Atherosclerosis Study Hypertension, June 1, 2004; 43(6): 1324 - 1331. [Abstract] [Full Text] [PDF]

				J. Skrha, T. Haas, G. Sindelka, M. Prazny, J. Widimsky, D. Cibula, and S. Svacina Comparison of the Insulin Action Parameters from Hyperinsulinemic Clamps with Homeostasis Model Assessment and QUICKI Indexes in Subjects with Different Endocrine Disorders J. Clin. Endocrinol. Metab., January 1, 2004; 89(1): 135 - 141. [Abstract] [Full Text] [PDF]

				Hypertension, Insulin, and Proinsulin in Participants With Impaired Glucose Tolerance Hypertension, November 1, 2002; 40(5): 679 - 686. [Abstract] [Full Text] [PDF]

				E. Bonora, G. Targher, M. Alberiche, R. C. Bonadonna, M. B. Zenere, F. Saggiani, and M. Muggeo Intracellular Partition of Plasma Glucose Disposal in Hypertensive and Normotensive Subjects with Type 2 Diabetes Mellitus J. Clin. Endocrinol. Metab., May 1, 2001; 86(5): 2073 - 2079. [Abstract] [Full Text]

				E. Bonora, G. Targher, M. Alberiche, R. C. Bonadonna, F. Saggiani, M. B. Zenere, S. Uleri, and M. Muggeo Effect of Chronic Treatment with Lacidipine or Lisinopril on Intracellular Partitioning of Glucose Metabolism in Type 2 Diabetes Mellitus J. Clin. Endocrinol. Metab., May 1, 1999; 84(5): 1544 - 1550. [Abstract] [Full Text]

				J. E. Gerich The Genetic Basis of Type 2 Diabetes Mellitus: Impaired Insulin Secretion versus Impaired Insulin Sensitivity Endocr. Rev., August 1, 1998; 19(4): 491 - 503. [Abstract] [Full Text] [PDF]

				I. Toft, K. H. Bonaa, and T. Jenssen Insulin Resistance in Hypertension Is Associated With Body Fat Rather Than Blood Pressure Hypertension, July 1, 1998; 32(1): 115 - 122. [Abstract] [Full Text] [PDF]

				G. Targher, M. Alberiche, M. B. Zenere, R. C. Bonadonna, M. Muggeo, and E. Bonora Cigarette Smoking and Insulin Resistance in Patients with Noninsulin-Dependent Diabetes Mellitus J. Clin. Endocrinol. Metab., November 1, 1997; 82(11): 3619 - 3624. [Abstract] [Full Text] [PDF]

				A. Jain, G. Avendano, S. Dharamsey, A. Dasmahapatra, R. Agarwal, A. Reddi, and T. Regan Left Ventricular Diastolic Function in Hypertension and Role of Plasma Glucose and Insulin : Comparison With Diabetic Heart Circulation, April 1, 1996; 93(7): 1396 - 1402. [Abstract] [Full Text]